Key Insights
The Australian respiratory therapeutic devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 5.50% from 2025 to 2033. This expansion is fueled by several key factors. The rising prevalence of chronic respiratory diseases like asthma, COPD, and sleep apnea, coupled with an aging population, significantly boosts demand for effective therapeutic devices. Technological advancements leading to the development of sophisticated, portable, and user-friendly devices further contribute to market growth. Increased awareness about respiratory health and the availability of home healthcare settings also play a crucial role. The market is segmented by device type (diagnostic and monitoring, therapeutic) and application (asthma, COPD, sleep apnea, other respiratory conditions). While the increasing cost of advanced devices and potential reimbursement challenges pose some restraints, the overall market outlook remains positive. Key players like ResMed, Fisher & Paykel Healthcare, and Philips are driving innovation and competition, enhancing market accessibility and affordability through strategic partnerships and product launches. Growth within the homecare segment is particularly strong, driven by a preference for convenient and less invasive treatment options.
The market's future trajectory is influenced by several trends. Government initiatives focusing on improving respiratory health outcomes and expanding access to healthcare will be instrumental in driving adoption. The integration of telehealth and digital health technologies for remote patient monitoring is also expected to significantly contribute to market expansion. Furthermore, the increasing focus on personalized medicine and the development of tailored treatment plans based on individual patient needs represent an exciting area of growth for respiratory therapeutic devices within the Australian market. Competition among existing players and the entry of new entrants is expected to drive innovation and enhance product offerings, benefitting patients and shaping the future landscape of this vital sector.

Australia Respiratory Therapeutic Devices Market: A Comprehensive Report (2019-2033)
This insightful report provides a detailed analysis of the Australia Respiratory Therapeutic Devices Market, encompassing historical data (2019-2024), the base year (2025), and a comprehensive forecast (2025-2033). It offers a crucial understanding of market dynamics, growth drivers, challenges, and future opportunities, equipping stakeholders with the knowledge necessary for strategic decision-making. The market is valued at AU$ xx Million in 2025 and is projected to reach AU$ xx Million by 2033, exhibiting a CAGR of xx% during the forecast period.
Australia Respiratory Therapeutic Devices Market Market Composition & Trends
This section delves into the intricate composition of the Australian respiratory therapeutic devices market, analyzing key trends shaping its evolution. We examine market concentration, revealing the market share distribution among leading players like ResMed Inc, Fisher & Paykel Healthcare Ltd, and Philips. The report further explores the innovative landscape, highlighting technological advancements driving market growth, and assesses the impact of the regulatory environment, including TGA approvals. Substitute products and their market impact are also discussed. End-user profiles, encompassing hospitals, clinics, and homecare settings, are meticulously detailed. Finally, we analyze mergers and acquisitions (M&A) activities, providing insights into deal values and their strategic implications. Market share data for key players will be provided, along with an analysis of M&A activity including deal values (where available).
- Market Concentration: Analysis of market share held by top players.
- Innovation Catalysts: Discussion of technological advancements driving market growth.
- Regulatory Landscape: Evaluation of TGA regulations and their impact.
- Substitute Products: Analysis of alternative treatments and their influence.
- End-User Profiles: Detailed description of key market segments (hospitals, clinics, homecare).
- M&A Activity: Analysis of significant M&A deals and their financial implications (with values where available).

Australia Respiratory Therapeutic Devices Market Industry Evolution
This section provides a comprehensive analysis of the Australia Respiratory Therapeutic Devices Market's evolutionary trajectory from 2019 to 2033. We analyze growth trajectories, technological advancements (e.g., smart inhalers, telehealth integration), and the evolving demands of patients and healthcare providers. Data points illustrating growth rates and adoption metrics for key device types (e.g., CPAP machines, nebulizers) will be presented, detailing the market's response to changing consumer preferences and technological disruption. The impact of government initiatives and healthcare policies on market expansion will also be explored.
Leading Regions, Countries, or Segments in Australia Respiratory Therapeutic Devices Market
This section identifies the dominant regions, countries, or segments within the Australian respiratory therapeutic devices market. We analyze performance across various categories, including:
- Type: Diagnostic and Monitoring Devices, Therapeutic Devices, Other Therapeutic Devices.
- Application: Asthma, COPD, Sleep Apnea, Other Respiratory Conditions.
- Setting: Homecare Settings
Key drivers for the dominance of specific segments will be explored using bullet points, such as investment trends, regulatory support, and patient demographics. In-depth analysis will determine why certain regions or segments are experiencing faster growth than others, explaining the factors contributing to their market leadership.
- Key Drivers (Examples):
- Increased prevalence of respiratory diseases (e.g., COPD, Asthma).
- Government funding and healthcare initiatives.
- Technological advancements in device design and functionality.
- Growing adoption of homecare settings.
Australia Respiratory Therapeutic Devices Market Product Innovations
This section highlights recent product innovations in the Australian respiratory therapeutic devices market. It will discuss the advancements in device functionality, miniaturization, data connectivity, and user-friendliness. Unique selling propositions (USPs) of leading products and their impact on market competition will be examined. Technological advancements, such as the integration of smart sensors and mobile applications for remote patient monitoring, will be detailed.
Propelling Factors for Australia Respiratory Therapeutic Devices Market Growth
Several factors are driving growth in the Australian respiratory therapeutic devices market. These include the increasing prevalence of chronic respiratory diseases like asthma and COPD, alongside rising healthcare expenditure and government initiatives promoting better respiratory health. Technological advancements, such as the development of smaller, more portable devices, and increasing telehealth adoption, also contribute to market expansion. Favorable regulatory policies supporting medical device innovation further fuel market growth.
Obstacles in the Australia Respiratory Therapeutic Devices Market Market
Despite strong growth potential, the Australian respiratory therapeutic devices market faces challenges. Regulatory hurdles related to device approvals and reimbursement can slow down market entry and expansion. Supply chain disruptions and increasing competition among established players can impact pricing and profitability. Furthermore, the high cost of advanced devices can limit access for some patients.
Future Opportunities in Australia Respiratory Therapeutic Devices Market
The Australian respiratory therapeutic devices market presents significant future opportunities. The expanding elderly population, increasing prevalence of respiratory illnesses, and rising adoption of home healthcare create a significant demand for advanced and user-friendly devices. The integration of digital health technologies and personalized medicine approaches will offer further opportunities for market expansion. New markets for innovative devices targeting niche respiratory conditions also hold substantial potential.
Major Players in the Australia Respiratory Therapeutic Devices Market Ecosystem
- DeVilbiss Healthcare LLC
- Invacare Corporation
- ResMed Inc
- GE Healthcare
- Medtronic PLC
- Chart Industries Inc
- Koninklijke Philips NV
- Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- GlaxoSmithKline PLC
Key Developments in Australia Respiratory Therapeutic Devices Market Industry
- October 2022: AirPhysio, an Australian company, partnered with Medsmart and Apollo Group to launch its respiratory devices in India, expanding its market reach and potentially influencing the Australian market through knowledge transfer and technological advancements.
- July 2022: Vivos Therapeutics received multiple Class I clearances from the TGA for its oral appliances to treat snoring and obstructive sleep apnea, signifying market expansion within the sleep apnea therapeutic segment in Australia.
Strategic Australia Respiratory Therapeutic Devices Market Market Forecast
The Australian respiratory therapeutic devices market is poised for robust growth driven by increasing prevalence of respiratory diseases, advancements in device technology, and rising healthcare expenditure. The integration of telehealth and personalized medicine offers further growth catalysts. The market's future potential rests on successfully addressing challenges such as affordability and ensuring equitable access to advanced respiratory devices.
Australia Respiratory Therapeutic Devices Market Segmentation
-
1. Type
-
1.1. Diagnostic and Monitoring Devices
- 1.1.1. Spirometers
- 1.1.2. Sleep Test Devices
- 1.1.3. Peak Flow Meters
- 1.1.4. Pulse Oximeters
- 1.1.5. Capnographs
- 1.1.6. Other Diagnostic and Monitoring Devices
-
1.2. Therapeutic Devices
- 1.2.1. CPAP Devices
- 1.2.2. BiPAP Devices
- 1.2.3. Humidifiers
- 1.2.4. Nebulizers
- 1.2.5. Oxygen Concentrators
- 1.2.6. Ventilators
- 1.2.7. Inhalers
- 1.2.8. Other Therapeutic Devices
-
1.3. Disposables
- 1.3.1. Masks
- 1.3.2. Breathing Circuits
- 1.3.3. Other Disposables
-
1.1. Diagnostic and Monitoring Devices
Australia Respiratory Therapeutic Devices Market Segmentation By Geography
- 1. Australia

Australia Respiratory Therapeutic Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.50% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Prevalence of Respiratory Disorders; Technological Advancements in Devices
- 3.3. Market Restrains
- 3.3.1. High Cost of Devices
- 3.4. Market Trends
- 3.4.1. Ventilators Segment is Expected to Show Better Growth in the Forecast Years
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Australia Respiratory Therapeutic Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Diagnostic and Monitoring Devices
- 5.1.1.1. Spirometers
- 5.1.1.2. Sleep Test Devices
- 5.1.1.3. Peak Flow Meters
- 5.1.1.4. Pulse Oximeters
- 5.1.1.5. Capnographs
- 5.1.1.6. Other Diagnostic and Monitoring Devices
- 5.1.2. Therapeutic Devices
- 5.1.2.1. CPAP Devices
- 5.1.2.2. BiPAP Devices
- 5.1.2.3. Humidifiers
- 5.1.2.4. Nebulizers
- 5.1.2.5. Oxygen Concentrators
- 5.1.2.6. Ventilators
- 5.1.2.7. Inhalers
- 5.1.2.8. Other Therapeutic Devices
- 5.1.3. Disposables
- 5.1.3.1. Masks
- 5.1.3.2. Breathing Circuits
- 5.1.3.3. Other Disposables
- 5.1.1. Diagnostic and Monitoring Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. Australia
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 DeVilbiss Healthcare LLC
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Invacare Corporation
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 ResMed Inc
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 GE Healthcare
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medtronic PLC
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Chart Industries Inc
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Koninklijke Philips NV
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Dragerwerk AG
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Fisher & Paykel Healthcare Ltd
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 GlaxoSmithKline PLC
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 DeVilbiss Healthcare LLC
List of Figures
- Figure 1: Australia Respiratory Therapeutic Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Australia Respiratory Therapeutic Devices Market Share (%) by Company 2024
List of Tables
- Table 1: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Type 2019 & 2032
- Table 4: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Type 2019 & 2032
- Table 5: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Type 2019 & 2032
- Table 10: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Type 2019 & 2032
- Table 11: Australia Respiratory Therapeutic Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: Australia Respiratory Therapeutic Devices Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Australia Respiratory Therapeutic Devices Market?
The projected CAGR is approximately 5.50%.
2. Which companies are prominent players in the Australia Respiratory Therapeutic Devices Market?
Key companies in the market include DeVilbiss Healthcare LLC, Invacare Corporation, ResMed Inc, GE Healthcare, Medtronic PLC, Chart Industries Inc, Koninklijke Philips NV, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GlaxoSmithKline PLC.
3. What are the main segments of the Australia Respiratory Therapeutic Devices Market?
The market segments include Type.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Respiratory Disorders; Technological Advancements in Devices.
6. What are the notable trends driving market growth?
Ventilators Segment is Expected to Show Better Growth in the Forecast Years.
7. Are there any restraints impacting market growth?
High Cost of Devices.
8. Can you provide examples of recent developments in the market?
October 2022: Australia-based AirPhysio partnered with Medsmart and Apollo Group to launch its respiratory devices in India. The device helps clean the lungs of mucus and pollutants for patients with respiratory conditions, such as asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Australia Respiratory Therapeutic Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Australia Respiratory Therapeutic Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Australia Respiratory Therapeutic Devices Market?
To stay informed about further developments, trends, and reports in the Australia Respiratory Therapeutic Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence